PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,603 | -30.1% | 30,900 | 0.0% | 0.00% | – |
| Q2 2023 | $73,851 | -22.9% | 30,900 | 0.0% | 0.00% | – |
| Q1 2023 | $95,790 | -42.2% | 30,900 | -50.0% | 0.00% | – |
| Q4 2022 | $165,624 | +82.0% | 61,800 | +100.0% | 0.00% | – |
| Q3 2022 | $91,000 | 0.0% | 30,900 | 0.0% | 0.00% | – |
| Q2 2022 | $91,000 | -42.4% | 30,900 | 0.0% | 0.00% | – |
| Q1 2022 | $158,000 | -21.4% | 30,900 | +3.7% | 0.00% | – |
| Q4 2021 | $201,000 | +27.2% | 29,800 | +30.7% | 0.00% | – |
| Q3 2021 | $158,000 | +56.4% | 22,800 | +120.1% | 0.00% | – |
| Q2 2021 | $101,000 | -89.3% | 10,359 | -82.8% | 0.00% | – |
| Q1 2021 | $946,000 | -21.9% | 60,133 | +20.2% | 0.00% | – |
| Q4 2020 | $1,211,000 | +212.9% | 50,033 | +117.4% | 0.00% | – |
| Q3 2020 | $387,000 | -27.3% | 23,018 | +26.8% | 0.00% | – |
| Q2 2020 | $532,000 | – | 18,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |